11,586
Views
38
CrossRef citations to date
0
Altmetric
Reviews

Vaccines and vaccination: history and emerging issues

ORCID Icon &
Pages 5255-5268 | Received 22 Jun 2021, Accepted 31 Aug 2021, Published online: 28 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (37)

A.C. Montagud, J. Llenas-García, R. Moragues, A. Pérez-Bernabeu, M.J. Alcocer Pertegal, F.J. García Gómez, A.M. Gamayo Serna, H. García Morante, P. Caballero & J. Tuells. (2024) Prevalencia de anticuerpos neutralizantes frente al SARS-CoV-2 inducidos tras 2 dosis de vacuna BNT162b2 (Pfizer–BioNTech) en trabajadores sanitarios. Revista Clínica Española.
Crossref
Robert J. Moore. (2024) Necrotic enteritis and antibiotic-free production of broiler chickens: Challenges in testing and using alternative products. Animal Nutrition 16, pages 288-298.
Crossref
Yufeng Song, Frances Mehl & Steven L. Zeichner. (2024) Vaccine Strategies to Elicit Mucosal Immunity. Vaccines 12:2, pages 191.
Crossref
Bowen Lu, Jing Ming Lim, Boyue Yu, Siyuan Song, Praveen Neeli, Navid Sobhani, Pavithra K, Srinivasa Reddy Bonam, Rajendra Kurapati, Junnian Zheng & Dafei Chai. (2024) The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects. Frontiers in Immunology 15.
Crossref
A.C. Montagud, J. Llenas-García, R. Moragues, A. Pérez-Bernabeu, M.J. Alcocer Pertegal, F.J. García Gómez, A.M. Gamayo Serna, H. García Morante, P. Caballero & J. Tuells. (2024) Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers of a Spanish Department of Health in Alicante (Spain) before the booster dose of the vaccine. Revista Clínica Española (English Edition).
Crossref
Atsuki Takeishi, Amina K. Shaban, Taichi Kakihana, Hayato Takihara, Shujiro Okuda, Hidekazu Osada, Desak Nyoman Surya Suameitria Dewi, Yuriko Ozeki, Yutaka Yoshida, Akihito Nishiyama, Yoshitaka Tateishi, Yuki Aizu, Yasushi Chuma, Kazuyo Onishi, Daisuke Hayashi, Saburo Yamamoto, Tetsu Mukai, Manabu Ato, Duong Huu Thai, Huynh Thi Thao Nhi, Tsuyoshi Shirai, Satoshi Shibata, Fumiko Obata, Jun Fujii, Seiya Yamayoshi, Maki Kiso & Sohkichi Matsumoto. (2024) Genetic engineering employing MPB70 and its promoter enables efficient secretion and expression of foreign antigen in bacillus Calmette Guérin (BCG) Tokyo. Microbiology and Immunology.
Crossref
D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, A. V. Zaborovsky, I. E. Makarenko, R. V. Drai, A. G. Solodovnikov, V. I. Petrov, K. N. Koryanova, N. A. Lycheva, S. A. Voskresensky, A. V. Strygin, Yu. A. Kolosov, Yu. V. Gorbunova & O. V. Ivanova. (2024) Methodological and regulatory aspects of pharmaceutical development of biological products. Pharmacy & Pharmacology 11:5, pages 384-398.
Crossref
Shubham Karpe, Khushi Gupta, Ganesh Vyas, Princy Rana, Fahad Khan & Rajesh Kumar. (2024) Virosome: A vector in vaccine delivery. BIO Web of Conferences 86, pages 01020.
Crossref
Garima Sahu, Priyanka Kumari & Amit K. Goyal. 2024. Molecular Pharmaceutics and Nano Drug Delivery. Molecular Pharmaceutics and Nano Drug Delivery 15 62 .
Sujit Pujhari. (2023) Recent Advances in Arboviral Vaccines: Emerging Platforms and Promising Innovations. Biologics 4:1, pages 1-16.
Crossref
Irma Casas, Karen Colmenares, Beatriz Blanco & Julia Valera. (2023) El valor de las vacunas en el siglo xxi. Medicina Clínica.
Crossref
Mehran Alavi & Ali Nokhodchi. (2023) Micro- and nanoformulations of antibiotics against Brucella. Drug Discovery Today 28:12, pages 103809.
Crossref
Duduzile Ndwandwe, Musawenkosi Ndlovu, Asanda Mayeye, Nomahlubi Luphondo, Ndivhuwo Muvhulawa, Yonela Ntamo, Phiwayinkosi V. Dludla & Charles S. Wiysonge. (2023) Trends in Vaccine Completeness in Children Aged 0–23 Months in Cape Town, South Africa. Vaccines 11:12, pages 1782.
Crossref
Alessio Romerio & Francesco Peri. (2023) Cleaner synthesis of preclinically validated vaccine adjuvants. Frontiers in Chemistry 11.
Crossref
Thinh To Quoc, Ildikó Bácskay, Pálma Fehér, Ádám Pallér, Boglárka Papp, Krisztina Bíró & Zoltán Ujhelyi. (2023) Personalized Nasal Protective Devices: Importance and Perspectives. Life 13:11, pages 2116.
Crossref
Francesca Romana Ponziani, Gaetano Coppola, Pierluigi Rio, Mario Caldarelli, Raffaele Borriello, Giovanni Gambassi, Antonio Gasbarrini & Rossella Cianci. (2023) Factors Influencing Microbiota in Modulating Vaccine Immune Response: A Long Way to Go. Vaccines 11:10, pages 1609.
Crossref
Alessio Romerio, Ana Rita Franco, Melanie Shadrick, Mohammed Monsoor Shaik, Valentina Artusa, Alice Italia, Federico Lami, Alexei V. Demchenko & Francesco Peri. (2023) Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity. ACS Omega 8:39, pages 36412-36417.
Crossref
Ingrid Glette‐Iversen, Terje Aven & Roger Flage. (2023) A risk science perspective on vaccines. Risk Analysis.
Crossref
A. V. Starshinin, T. N. Elagina, Yu. B. Novikova, G. N. Gribanovskaya, N. N. Kamynina & O. I. Nechaev. (2023) Organization of Mass Vaccine Prevention in the Conditions of a Modern Megapolis. Epidemiology and Vaccinal Prevention 22:4, pages 95-105.
Crossref
Soichiro Sato, Satoshi Arai, Noriyuki Iwabuchi, Miyuki Tanaka, Ryosuke Hase & Naoki Sakane. (2023) Effects of Heat-Killed Lacticaseibacillus paracasei MCC1849 on the Maintenance of Physical Condition in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study. Nutrients 15:15, pages 3450.
Crossref
Judith Green-McKenzie, Catherine Field-Flowers, Kimberly Peairs, Kenneth Barnes, Frances Shofer & Barbara J. Kuter. (2023) Best Practices for Implementation of an Employee Health COVID-19 Vaccine Clinic—A Model for Future Pandemic Preparedness. Journal of Occupational & Environmental Medicine 65:8, pages 621-626.
Crossref
Ohoud S. Almalki, Eman Y. Santali, Abdulaziz A. Alhothali, Ashraf A. Ewis, Abeer Shady, Ahmed Ibrahim Fathelrahman & Sayed F. Abdelwahab. (2023) The role of blood groups, vaccine type and gender in predicting the severity of side effects among university students receiving COVID-19 vaccines. BMC Infectious Diseases 23:1.
Crossref
Shruti Srivastava, Sajal Dey & Sangita Mukhopadhyay. (2023) Vaccines against Tuberculosis: Where Are We Now?. Vaccines 11:5, pages 1013.
Crossref
Jukito Sonoda, Izuru Mizoguchi, Shinya Inoue, Aruma Watanabe, Ami Sekine, Miu Yamagishi, Satomi Miyakawa, Natsuki Yamaguchi, Eri Horio, Yasuhiro Katahira, Hideaki Hasegawa, Takashi Hasegawa, Kunihiko Yamashita & Takayuki Yoshimoto. (2023) A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant. International Journal of Molecular Sciences 24:10, pages 9094.
Crossref
Taimur Haider, Syeda Rakshan Zehra Abidi, Mehwish Fatima, Aimen Zafar, Rabeeya Qutub Uddin Siddiqui, Wadan Khan, Tazeen Saeed, Adnan Anwar & Atif A Hashmi. (2023) The Prevalence of Side Effects of Sinopharm COVID-19 Vaccine: An Experience From Pakistan. Cureus.
Crossref
Alessio Romerio, Nicole Gotri, Ana Rita Franco, Valentina Artusa, Mohammed Monsoor Shaik, Samuel T. Pasco, Unai Atxabal, Alejandra Matamoros-Recio, Marina Mínguez-Toral, Juan Diego Zalamea, Antonio Franconetti, Nicola G. A. Abrescia, Jesus Jimenez-Barbero, Juan Anguita, Sonsoles Martín-Santamaría & Francesco Peri. (2023) New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants. Journal of Medicinal Chemistry 66:4, pages 3010-3029.
Crossref
Feng Xu, Ye Yuan, Ying Wang & Qiliang Yin. (2023) Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection. Biomedicine & Pharmacotherapy 158, pages 114117.
Crossref
Ahmet Özdinç, Mehmet Sait Değer, Muhammed Atak & İbrahim Demir. (2023) Talking about the Vaccine after the Pandemic: A Cross-Sectional Study among Youth in Turkey and Ethical Issues. Vaccines 11:1, pages 104.
Crossref
Sara Eslait-Olaciregui, Kevin Llinás-Caballero, David Patiño-Manjarrés, Thomas Urbina-Ariza, Juan Fernando Cediel-Becerra & Camilo Alberto Domínguez-Domínguez. (2023) Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature. Therapeutic Advances in Drug Safety 14, pages 204209862311656.
Crossref
Ishani Banerji, Shreya Bhattacharjee, Kamalika Mukherjee & Suvendra N. Bhattacharyya. 2023. Nucleic Acid Biology and its Application in Human Diseases. Nucleic Acid Biology and its Application in Human Diseases 349 364 .
Aytül Gül, Sedef Erkunt Alak, Ceren Gül, Tuğba Karakavuk, Hüseyin Can, Muhammet Karakavuk, Ahmet Efe Köseoğlu, Mert Döşkaya, Elif Esin Hameş, Cemal Ün, Adnan Yüksel Gürüz & Aysu Değirmenci Döşkaya. 2023. A Sustainable Green Future. A Sustainable Green Future 183 212 .
Felipe Andrade-Guerrero, Adriana Tapia, Vinicio Andrade, Jorge Vásconez-González, José Andrade-Guerrero, Carlos Noroña-Calvachi, Juan S. Izquierdo-Condoy, Justin Yeager & Esteban Ortiz-Prado. (2022) False Contraindications for Vaccinations Result in Sub-Optimal Vaccination Coverage in Quito, Ecuador: A Cross-Sectional Study. Vaccines 11:1, pages 60.
Crossref
Harriet Itiakorit, Abhilash Sathyamoorthi, Brigid E. O’Brien & Diane Nguyen. (2022) COVID-19 Impact on Disparity in Childhood Immunization in Low- and Middle-Income Countries Through the Lens of Historical Pandemics. Current Tropical Medicine Reports 9:4, pages 225-233.
Crossref
Bin Yang, Zi‐Rao Guo, Zhao Zhao, Tao Wang, Fei Yang, Fei Ling, Bin Zhu & Gao‐Xue Wang. (2022) Protective immunity by DNA vaccine against Micropterus salmoides rhabdovirus . Journal of Fish Diseases 45:10, pages 1429-1437.
Crossref
Hannah Roland, Amanda Brown, Amy Rousselot, Natalie Freeman, J. Wieting, Stephen Bergman & Debasis Mondal. (2022) Osteopathic Manipulative Treatment Decreases Hospital Stay and Healthcare Cost in the Neonatal Intensive Care Unit. Medicines 9:10, pages 49.
Crossref
Veysel Kayser. (2022) Meet the Editorial Board Member. Current Pharmaceutical Biotechnology 23:11, pages 1313-1314.
Crossref
Barbaros Eroglu, Rina Fajri Nuwarda, Iqbal Ramzan & Veysel Kayser. (2021) A Narrative Review of COVID-19 Vaccines. Vaccines 10:1, pages 62.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.